Making the Case: TCC-EZ

Share this article

Making the Case: TCC-EZ

12 January 2016

Prevalence of diabetes continues apace in the UK and the knock-on effect of this on patients, clinicians and the economy should not be understated.

Some 80% of UK spend on diabetes is used to treat complications associated with the condition: £600m–£700m is spent each year on ulcers and amputations. With common complications of diabetes now carrying higher mortality rates than a number of cancers, including breast and prostate cancer, the need for interventions that improve healing and reduce re-ulceration rates has never been greater.

This Making the Case looks at the positive outcomes for both patients and the NHS of using non-removable Total Contact Casts in the treatment of DFUs.

Free for all healthcare professionals

Sign up to the Wounds Group journals

By clicking ‘Subscribe’, you are agreeing that the Wounds Group are able to email you periodic newsletters. You may unsubscribe from these at any time. Your info is safe with us and we will never sell or trade your details. For information please review our privacy policy.

Are you a healthcare professional? This website is for healthcare professionals only. To continue, please confirm that you are a healthcare professional below.

We use cookies responsibly to ensure that we give you the best experience on our website. If you continue without changing your browser settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies.

I am not a healthcare professional.